Information about Amyl Therapeutics
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0758.775.372

VAT liability
Yes
Established
26-11-2020
Last balance sheet year
2024
Company size
Medium-sized 4,6 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Amyl Therapeutics

2024 2023 2022 2021
Profit/Loss -2,436,601 -43 % -1,709,641 -21 % -1,415,300 -42 % -999,692
Equity 5,562,413 -30 % 7,999,014 29 % 6,208,656 -19 % 7,623,956
Gross margin -872,434 -29 % -674,399 20 % -840,592 4 % -875,058
Employees 4.6 4.6 2.3 0.7

Publications from Amyl Therapeutics

Date Publication
04-02-2025 Capital, Shares - Miscellaneous (FR)
14-05-2024 Registered Office Relocation (FR)
12-02-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
12-09-2023 Capital, Shares (FR)
12-04-2023 Capital, Shares (FR)

Frequently asked questions

What is the VAT number of Amyl Therapeutics?
The VAT number of Amyl Therapeutics is BE 0758.775.372.
Wat is the PEPPOL ID of Amyl Therapeutics?
There is no information available about the PEPPOL ID of Amyl Therapeutics or the company is not yet registered on the PEPPOL network.
When was Amyl Therapeutics founded?
Amyl Therapeutics was founded on 26-11-2020.
What is the address of Amyl Therapeutics?
The current registered office of Amyl Therapeutics is located at Boulevard de Patience et Beaujonc 3, 4000 Liège.
When was the last time Amyl Therapeutics filed their annual financial statements?
The most recent financial statements of Amyl Therapeutics were filed on 08-07-2025.
How many employees does Amyl Therapeutics have?
There are 4,6 FTEs working at Amyl Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Amyl Therapeutics?
At the time of its most recent financial statements, Amyl Therapeutics did not publish any turnover figures. Amyl Therapeutics reported a gross margin of -€872,434.19.